Further to the Company’s announcement made on 24 May 2022 in relation to the deviation between the actual transacted value of the RRPTs and estimated value of the RRPTs by 10% or more, the Company wishes to announce that the actual transacted value of the RRPTs as at 30 May 2022 has exceeded the actual transacted value of the RRPTs as disclosed in the announcement made by the Company on 24 May 2022 by more than 10% of the estimate value of the RRPTs.
Details are as follows:
Nature of Transactions
|
Transacting Parties
|
Class of Related Party
|
Estimated value of RRPTs disclosed in the Circular to Shareholders dated 28 April 2021
("Mandate Value")
(RM '000)
|
Actual value of the RRPTs transacted from 05 June 2021 to 30 April 2022
("Actual
Value 1")
(RM '000)
|
Variation between Actual Value 1 and Mandate Value (%)
|
Actual value of the RRPTs transacted from 05 June 2021 to 30 May 2022
("Actual
Value 2")
(RM '000)
|
Variation between Actual Value 1 and Actual Value 2 (%)
|
Manulife Centre of Excellence (“COE”) – Operations and Information Technology (“IT”) Support Services
|
Manulife Investment Management (M) Berhad
|
Manulife Financial Corporation and its subsidiaries
|
2,800
|
3,223
|
15%
|
3,720
|
15%
|
Reason:
The RRPTs have exceeded the Mandate Value due to the hiring of new COE-IT resources (two (2) new full-time employees) at the start of the second half of year 2021 to support regional demand.
|
This announcement is dated 16 June 2022.